Search research articles
Contact Us
Filters
Showing results (101-110 of 322) with videos related to
Page
of 33
Sort By:
Seminars in Neurology
|
January 14, 2003
Neuromyelitis optica
Bruce A C Cree, Douglas S Goodin, Stephen L Hauser
Annals of Neurology
|
December 24, 2025
Reply to "New Horizons for Multiple Sclerosis Therapy: 2025 and Beyond"
Joseph J Sabatino, Bruce A C Cree, Stephen L Hauser
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
July 12, 2017
Ocrelizumab and Other CD20<sup>+</sup> B-Cell-Depleting Therapies in Multiple Sclerosis
Jeffrey M Gelfand, Bruce A C Cree, Stephen L Hauser
The Lancet. Neurology
|
February 19, 2022
Multiple sclerosis: two decades of progress
Bruce A C Cree, Jorge R Oksenberg, Stephen L Hauser
Nature Reviews. Genetics
|
June 11, 2008
The genetics of multiple sclerosis: SNPs to pathways to pathogenesis
Jorge R Oksenberg, Sergio E Baranzini, Stephen Sawcer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
February 1, 2012
Color vision is strongly associated with retinal thinning in multiple sclerosis
Pablo Villoslada, Ami Cuneo, Jeffrey Gelfand, et al.
Seminars in Neurology
|
December 6, 2017
Advances in Imaging Multiple Sclerosis
Antje Bischof, Eduardo Caverzasi, Christian Cordano, et al.
Immunogenetics
|
March 11, 2006
Restrictive and diversifying elements of the anti-myelin/oligodendrocyte glycoprotein antibody response in primate experimental allergic encephalomyelitis
H-Christian von Büdingen, Til Menge, Stephen L Hauser, et al.
Immunological Reviews
|
June 26, 2012
The genetics of multiple sclerosis: an up-to-date review
Pierre-Antoine Gourraud, Hanne F Harbo, Stephen L Hauser, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 23, 2002
The human T cell response to myelin oligodendrocyte glycoprotein: a multiple sclerosis family-based study
Niklas K U Koehler, Claude P Genain, Barbara Giesser, et al.
Page
of 33
Search research articles
Search
Showing results (101-110 of 322) with videos related to
Sort By:
Page
of 33
Seminars in Neurology
|
January 14, 2003
Neuromyelitis optica
Bruce A C Cree, Douglas S Goodin, Stephen L Hauser
Annals of Neurology
|
December 24, 2025
Reply to "New Horizons for Multiple Sclerosis Therapy: 2025 and Beyond"
Joseph J Sabatino, Bruce A C Cree, Stephen L Hauser
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
July 12, 2017
Ocrelizumab and Other CD20<sup>+</sup> B-Cell-Depleting Therapies in Multiple Sclerosis
Jeffrey M Gelfand, Bruce A C Cree, Stephen L Hauser
The Lancet. Neurology
|
February 19, 2022
Multiple sclerosis: two decades of progress
Bruce A C Cree, Jorge R Oksenberg, Stephen L Hauser
Nature Reviews. Genetics
|
June 11, 2008
The genetics of multiple sclerosis: SNPs to pathways to pathogenesis
Jorge R Oksenberg, Sergio E Baranzini, Stephen Sawcer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
February 1, 2012
Color vision is strongly associated with retinal thinning in multiple sclerosis
Pablo Villoslada, Ami Cuneo, Jeffrey Gelfand, et al.
Seminars in Neurology
|
December 6, 2017
Advances in Imaging Multiple Sclerosis
Antje Bischof, Eduardo Caverzasi, Christian Cordano, et al.
Immunogenetics
|
March 11, 2006
Restrictive and diversifying elements of the anti-myelin/oligodendrocyte glycoprotein antibody response in primate experimental allergic encephalomyelitis
H-Christian von Büdingen, Til Menge, Stephen L Hauser, et al.
Immunological Reviews
|
June 26, 2012
The genetics of multiple sclerosis: an up-to-date review
Pierre-Antoine Gourraud, Hanne F Harbo, Stephen L Hauser, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 23, 2002
The human T cell response to myelin oligodendrocyte glycoprotein: a multiple sclerosis family-based study
Niklas K U Koehler, Claude P Genain, Barbara Giesser, et al.
Page
of 33